{{Rsnum
|rsid=7203315
|Gene=GRIN2A
|Chromosome=16
|position=10094203
|Orientation=plus
|GMAF=0.1483
|Gene_s=GRIN2A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 75.2 | 23.9 | 0.9
| HCB | 94.9 | 5.1 | 0.0
| JPT | 81.4 | 15.9 | 2.7
| YRI | 41.5 | 51.7 | 6.8
| ASW | 47.4 | 43.9 | 8.8
| CHB | 94.9 | 5.1 | 0.0
| CHD | 91.7 | 8.3 | 0.0
| GIH | 77.2 | 20.8 | 2.0
| LWK | 48.2 | 42.7 | 9.1
| MEX | 87.9 | 12.1 | 0.0
| MKK | 65.4 | 27.6 | 7.1
| TSI | 70.6 | 26.5 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=T
  |Pval=4E-6
  |OR=15.83
  |ORtxt=[9.13-22.53] mg/dL increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}